BioPharm International
October 01, 2009
Issue PDF
22
10
Implementing Toyota’s LEAN Systems in Bioprocessing
October 01, 2009
Burrill on Biotech
22
10
Biotech impressed investors with positive drug data, strong drug sales and earnings, and partnering deals.
October 01, 2009
Features
22
10
Ten biopharmaceuticals gained marketing authorization in the US or EU in 2008, although only four were new approvals.
October 01, 2009
Manufacturing Economics Series
22
10
A step-by-step approach is essential for successful implementation.
October 01, 2009
Features
22
10
Automated in-line dilution can help solve capacity, financial, and quality concerns that biopharmaceutical manufacturing plants may be facing.
October 01, 2009
From the Editor
22
10
It seems clear that insuring the roughly 46 million Americans who are now uninsured will increase drug sales.
October 01, 2009
Final Word
22
10
Small changes can have a big effect further downstream in your manufacturing processes.
October 01, 2009
Outsourcing Insights
22
10
Lonza's bid for Patheon makes the contract manufacturing industry re-examine the one-stop manufacturer model.
October 01, 2009
Regulatory Beat
22
10
Stiffer enforcement of quality standards aims to restore public confidence in agency actions.